Edition:
India

Aptevo Therapeutics Inc (APVO.OQ)

APVO.OQ on NASDAQ Stock Exchange Global Select Market

1.85USD
2:00am IST
Change (% chg)

$-0.10 (-5.13%)
Prev Close
$1.95
Open
$1.98
Day's High
$1.98
Day's Low
$1.81
Volume
40,597
Avg. Vol
16,796
52-wk High
$6.30
52-wk Low
$1.81

Latest Key Developments (Source: Significant Developments)

Aptevo Therapeutics Announces Expanded Growth Initiatives
Wednesday, 24 Oct 2018 

Oct 24 (Reuters) - Aptevo Therapeutics Inc ::APTEVO THERAPEUTICS ANNOUNCES EXPANDED GROWTH INITIATIVES FOR IXINITY.APTEVO THERAPEUTICS INC - PLANS TO INTRODUCE 3000 IU IXINITY ASSAY.APTEVO THERAPEUTICS INC - WILL COMMENCE PEDIATRIC STUDY SEEKING U.S. LABEL EXPANSION.APTEVO THERAPEUTICS INC - EXPLORES EX-US LICENSING AND PARTNERSHIP COLLABORATIONS TO EXPAND INTERNATIONAL IXINITY FOOTPRINT.APTEVO - PLANS TO COMMENCE PHASE 4 STUDY OF IXINITY IN ABOUT 20 PATIENTS UNDER 12 YRS AGE FOR POTENTIAL LABEL EXPANSION OF IXINITY IN PEDIATRIC SETTING.APTEVO THERAPEUTICS INC - ANTICIPATES NEW 3000 IU VIAL ASSAY FOR IXINITY WILL BE AVAILABLE IN MID-2019.APTEVO THERAPEUTICS INC - ANTICIPATES LAUNCH OF NEW 3000 IU VIAL ASSAY FOR IXINITY WILL BE AVAILABLE IN MID-2019.  Full Article

Aptevo Therapeutics Announces Plans To Conduct Phase 2 Study Of Otlertuzumab In Peripheral T-Cell Lymphoma
Tuesday, 28 Nov 2017 

Nov 28 (Reuters) - Aptevo Therapeutics Inc ::APTEVO THERAPEUTICS ANNOUNCES PLANS TO CONDUCT PHASE 2 STUDY OF OTLERTUZUMAB IN PERIPHERAL T-CELL LYMPHOMA.APTEVO THERAPEUTICS INC- ‍EXPECTS TO FILE 2 IND APPLICATIONS IN 2018 FOR 2 BISPECIFIC ANTIBODY CANDIDATES, APVO436 AND APVO210​.  Full Article

Aptevo Therapeutics files mixed shelf of up to $150 mln
Monday, 13 Nov 2017 

Nov 13 (Reuters) - Aptevo Therapeutics Inc :Aptevo Therapeutics Inc files for mixed shelf of up to $150 million - SEC filing‍​.  Full Article

Aptevo Therapeutics reports third quarter 2017 financial results
Friday, 10 Nov 2017 

Nov 9 (Reuters) - Aptevo Therapeutics Inc :Aptevo Therapeutics reports third quarter 2017 financial results.Q3 earnings per share $1.77.  Full Article